# æ–‡ç»ç¸½è¦½ç´¢å¼•

**æœ€å¾Œæ›´æ–°**ï¼š2025-11-13
**ç”¨é€”**ï¼šçµ±æ•´æ‰€æœ‰å·²è®€è«–æ–‡çš„ç‹€æ…‹èˆ‡åˆ†é¡

---

## ğŸ“Š é–±è®€ç‹€æ…‹ç¸½è¦½

| ç‹€æ…‹ | æ•¸é‡ | èªªæ˜ |
|------|------|------|
| âœ… å·²å®Œæ•´åˆ†æï¼ˆæœ‰æ·±åº¦è§£æï¼‰ | 1 | Liu et al. 2024 |
| ğŸ“Œ é«˜å„ªå…ˆç´šå¾…æ·±å…¥åˆ†æ | 2 | Dual Framework 2025, Hung et al. 2021 |
| ğŸ“‹ åŸºæœ¬è³‡è¨Šå·²æ•´ç† | å¤šç¯‡ | è¦‹ç³»çµ±æ€§æ–‡ç»å›é¡§ |

---

## ğŸ¯ æŒ‰ç–¾ç—…åˆ†é¡

### é«˜è¡€å£“ï¼ˆHypertensionï¼‰

#### âœ… Hung et al. (2021) - éš±åŒ¿æ€§é«˜è¡€å£“é æ¸¬
- **æœŸåˆŠ**ï¼šFrontiers in Cardiovascular Medicine, 8:778306
- **DOI**ï¼š[10.3389/fcvm.2021.778306](https://doi.org/10.3389/fcvm.2021.778306)
- **PDFä½ç½®**ï¼š[fcvm-08-778306.pdf](../references/fcvm-08-778306.pdf)
- **è³‡æ–™**ï¼šå°ç£å…­å®¶é†«å­¸ä¸­å¿ƒ + å°åŒ—æ¦®ç¸½ï¼Œ970+416äºº
- **æ–¹æ³•**ï¼šLR, RF, XGBoost, ANN + SMOTE-NC
- **æœ€ä½³æ¨¡å‹**ï¼šRF (AUC 0.851/0.837)
- **é—œéµç‰¹å¾µ**ï¼šDBP, MAP, SBP, PP, beta-blocker, HDL-C
- **ç‹€æ…‹**ï¼šğŸ“Œ æœ‰PDFï¼Œé«˜å„ªå…ˆç´šå¾…æ·±å…¥åˆ†æ
- **ç›¸é—œæ–‡æª”**ï¼š[Q2_Taiwan_Literature_Review.md](../research_plans/Q2_Taiwan_Literature_Review.md)

#### ğŸ“‹ Lin et al. (2024) - è¡€æ¸…å°¿é…¸èˆ‡é«˜è¡€å£“é—œä¿‚
- **æœŸåˆŠ**ï¼šFrontiers in Endocrinology
- **DOI**ï¼š10.3389/fendo.2024.1343998
- **æ¨™é¡Œ**ï¼šPoor serum uric acid control increases the risk of hypertension
- **è³‡æ–™**ï¼šä¸­åœ‹ï¼Œ6,052äººï¼Œè¿½è¹¤6å¹´
- **ç™¼ç¾**ï¼šå°¿é…¸æ°´å¹³è®ŠåŒ–èˆ‡é«˜è¡€å£“é¢¨éšªå‘ˆç·šæ€§ç›¸é—œ
- **ç‹€æ…‹**ï¼šğŸ“‹ åŸºæœ¬è³‡è¨Šå·²æ•´ç†
- **é–±è®€æ—¥æœŸ**ï¼š2025-09-09

---

### ç³–å°¿ç—…ï¼ˆDiabetesï¼‰

#### âœ… Liu et al. (2024) - å°ç£ç¬¬äºŒå‹ç³–å°¿ç—…ç™¼ç—…é æ¸¬
- **æœŸåˆŠ**ï¼šDiagnostics, 15(1), 72
- **DOI**ï¼š[10.3390/diagnostics15010072](https://doi.org/10.3390/diagnostics15010072)
- **PDFä½ç½®**ï¼š[diagnostics-15-00072.pdf](../references/diagnostics-15-00072.pdf)
- **è³‡æ–™**ï¼šå°ä¸­æ¦®ç¸½EHRï¼Œ6,687äººï¼Œè¿½è¹¤10å¹´
- **æ–¹æ³•**ï¼šLR, RF, XGBoost
- **æœ€ä½³æ¨¡å‹**ï¼šXGBoost (AUC 0.93)
- **é—œéµç‰¹å¾µ**ï¼šHbA1c, FBG, Weight, fT4, TG
- **ç‹€æ…‹**ï¼šâœ… å·²å®Œæ•´åˆ†æ
- **ç›¸é—œæ–‡æª”**ï¼š
  - [Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md](Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md)
  - ç°¡å ±æª”ï¼šmeeting15_21138X006_ç´€ä¼¯å–¬_wVBA.pptm (å·²å ±å‘Šå®Œæˆ)

#### ğŸ“Œ Dual Framework (2025) - å°ç£é’å¹´ç”·æ€§å‰é©…ç³–å°¿ç—…é æ¸¬ â­â­â­â­â­
- **æœŸåˆŠ**ï¼šDiagnostics, 15(19), 2507
- **DOI**ï¼š[10.3390/diagnostics15192507](https://doi.org/10.3390/diagnostics15192507)
- **PDFä½ç½®**ï¼š[diagnostics-15-02507.pdf](../references/diagnostics-15-02507.pdf) (3.5 MB)
- **è³‡æ–™**ï¼šå°ç£ MJ å¥åº·ç¯©æª¢ä¸­å¿ƒï¼Œ6,247äºº (18-35æ­²ç”·æ€§)ï¼Œè¿½è¹¤5.9å¹´
- **æ–¹æ³•**ï¼šé›™æ¡†æ¶ (é€£çºŒå€¼Î´-FPG + äºŒå…ƒåˆ†é¡) | RF, SGB, XGBoost, Elastic Net
- **å¯è§£é‡‹æ€§**ï¼šSHAP
- **é—œéµç™¼ç¾**ï¼šÎ´-FPG (è¡€ç³–è®ŠåŒ–é‡) é æ¸¬ï¼Œèˆ‡æœ¬ç ”ç©¶çš„ Î” ç‰¹å¾µæ¦‚å¿µç›¸åŒ
- **ç‹€æ…‹**ï¼šğŸ“Œ **é«˜å„ªå…ˆç´šå¾…æ·±å…¥åˆ†æï¼ˆMeeting 17 é‡é»ï¼‰**
- **èˆ‡æœ¬ç ”ç©¶é—œè¯åº¦**ï¼šâ­â­â­â­â­ (æœ€é«˜)
  - ç¸±å‘è®ŠåŒ–é‡ç‰¹å¾µï¼ˆÎ´-FPG = Î”ç‰¹å¾µï¼‰
  - é›™æ¡†æ¶è¨­è¨ˆï¼ˆé€£çºŒå€¼ + åˆ†é¡ï¼‰
  - SHAP å¯è§£é‡‹æ€§
  - å°ç£æœ¬åœŸè³‡æ–™
  - è¡€æ¶²æª¢é©—é …ç›®å®Œæ•´ï¼ˆå«å°¿é…¸ï¼‰
- **ç›¸é—œæ–‡æª”**ï¼š[Meeting_17_Preparation_Plan.md](../meeting_notes/Meeting_17_Preparation_Plan.md)
- **è¨ˆç•«å»ºç«‹æ–‡æª”**ï¼š
  - [ ] `Dual_2025_æ·±åº¦è§£æ.md`
  - [ ] `Dual_2025_æ¼”è¬›ç¨¿_10é .md`

---

### é«˜è¡€è„‚ï¼ˆDyslipidemiaï¼‰

âš ï¸ **å°ç£é«˜è¡€è„‚é æ¸¬ç ”ç©¶è¼ƒå°‘**ï¼Œä¸»è¦ç‚ºåœ‹éš›ç ”ç©¶ï¼ˆè¦‹ç³»çµ±æ€§æ–‡ç»å›é¡§ï¼‰

---

### ä»£è¬ç—‡å€™ç¾¤ï¼ˆMetabolic Syndromeï¼‰

#### ğŸ“‹ å°ç£æˆäººä»£è¬ç—‡å€™ç¾¤ç›¸é—œç ”ç©¶
- å¤šç¯‡å°ç£æœ¬åœŸç ”ç©¶ï¼ˆ2006-2020ï¼‰
- æ–¹æ³•ï¼šPCA, Decision Tree, ANN
- ç‹€æ…‹ï¼šåŸºæœ¬è³‡è¨Šå·²æ•´ç†
- ç›¸é—œæ–‡æª”ï¼š[Q2_Taiwan_Literature_Review.md](../research_plans/Q2_Taiwan_Literature_Review.md)

---

## ğŸ“‚ æŒ‰æ–‡ç”é¡å‹åˆ†é¡

### æ·±åº¦è§£ææ–‡æª”ï¼ˆå·²å®Œæˆï¼‰

1. [Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md](Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md)
   - ç ”ç©¶è¨­è¨ˆã€æ–¹æ³•ã€çµæœã€è¨è«–çš„å®Œæ•´åˆ†æ
   - èˆ‡æœ¬ç ”ç©¶çš„é—œè¯æ€§åˆ†æ
   - å•Ÿç¤ºèˆ‡å»ºè­°

### æ¼”è¬›ç¨¿æ–‡æª”ï¼ˆå·²å®Œæˆï¼‰

1. [Liu_2024_æ¼”è¬›ç¨¿_10é .md](Liu_2024_æ¼”è¬›ç¨¿_10é .md)
2. [Liu_2024_æ¼”è¬›ç¨¿_10é _ç²¾ç°¡ç‰ˆ.md](Liu_2024_æ¼”è¬›ç¨¿_10é _ç²¾ç°¡ç‰ˆ.md)

### ç¶œåˆæ–‡ç»å›é¡§æ–‡æª”

1. [Q2_Taiwan_Literature_Review.md](../research_plans/Q2_Taiwan_Literature_Review.md)
   - å°ç£ä¸‰é«˜é æ¸¬ç›¸é—œæ–‡ç»çš„ç³»çµ±æ€§æ•´ç†
   - æŒ‰ç–¾ç—…åˆ†é¡çš„è©³ç´°åˆ†æ
   - ç ”ç©¶ç¼ºå£èˆ‡æœ¬ç ”ç©¶çš„è²¢ç»

2. [Systematic_Literature_Review.md](Systematic_Literature_Review.md)
   - ç³»çµ±æ€§æ–‡ç»å›é¡§è¡¨æ ¼ï¼ˆ15ç¯‡åœ‹éš›ç ”ç©¶ï¼‰
   - æŒ‰ç ”ç©¶æ¨™çš„ã€æ–¹æ³•ã€è³‡æ–™é›†åˆ†é¡

3. [literature_review_memo.md](literature_review_memo.md)
   - æ—©æœŸæ–‡ç»é–±è®€ç­†è¨˜ï¼ˆ2025-09-09ï¼‰

### å…¶ä»–åƒè€ƒæ–‡æª”

1. [confusion_matrix_metrics.md](confusion_matrix_metrics.md)
   - è©•ä¼°æŒ‡æ¨™èªªæ˜

---

## ğŸ¯ Meeting 17 æº–å‚™é‡é»

### å„ªå…ˆä»»å‹™

1. **æ·±å…¥ç ”ç©¶ Dual Framework 2025** ğŸ“Œ
   - [x] ä¸‹è¼‰ä¸¦åˆæ­¥é–±è®€å®Œæ•´è«–æ–‡ï¼ˆ2025-11-13å·²å®Œæˆï¼‰
   - [ ] å»ºç«‹æ·±åº¦è§£ææ–‡æª”
   - [ ] åˆ†æ Î´-FPG ç‰¹å¾µå·¥ç¨‹æ–¹æ³•
   - [ ] ç ”ç©¶é›™æ¡†æ¶è¨­è¨ˆ
   - [ ] å­¸ç¿’ SHAP æ‡‰ç”¨
   - [ ] è£½ä½œ10é ç°¡å ±

2. **æ·±å…¥åˆ†æ Hung et al. 2021** âš ï¸
   - [ ] é–±è®€å·²ä¸‹è¼‰çš„ PDF
   - [ ] åˆ†æç‰¹å¾µé¸æ“‡æ–¹æ³•
   - [ ] ç ”ç©¶å¤–éƒ¨é©—è­‰ç­–ç•¥
   - [ ] æ•´ç†é«˜è¡€å£“é æ¸¬é—œéµç‰¹å¾µ

---

## ğŸ“Œ ç ”ç©¶æ–¹æ³•è«–ç¸½çµ

### å¸¸ç”¨æ¨¡å‹ï¼ˆæŒ‰å°ç£æ–‡ç»å‡ºç¾é »ç‡ï¼‰

1. **Random Forest** - å¤šç¯‡ç ”ç©¶è¡¨ç¾å„ªç•°
2. **XGBoost** - ç³–å°¿ç—…é æ¸¬æœ€ä½³ (Liu 2024: AUC 0.93)
3. **Logistic Regression** - åŸºæº–æ¨¡å‹
4. **SVM, ANN** - ç‰¹å®šæƒ…å¢ƒæœ‰å„ªå‹¢

### å¸¸ç”¨è³‡æ–™è™•ç†æŠ€è¡“

1. **é¡åˆ¥ä¸å¹³è¡¡**ï¼šSMOTE, SMOTE-NC, Over/Under-sampling
2. **ç¼ºå¤±å€¼**ï¼šMean imputation, KNN
3. **æ¨™æº–åŒ–**ï¼šZ-score normalization
4. **ç‰¹å¾µé¸æ“‡**ï¼šLASSO, RF feature importance, SHAP

### è©•ä¼°æŒ‡æ¨™ï¼ˆæ¨è–¦ï¼‰

- **ä¸»è¦**ï¼šAUC-ROCï¼ˆè™•ç†ä¸å¹³è¡¡è³‡æ–™ï¼‰
- **æ¬¡è¦**ï¼šAccuracy, Precision, Recall, F1-Score
- **è‡¨åºŠ**ï¼šSensitivity, Specificity, NPV, PPV
- **ç©©å®šæ€§**ï¼šäº¤å‰é©—è­‰ã€å¤–éƒ¨é©—è­‰

---

## ğŸ” ç ”ç©¶ç¼ºå£åˆ†æ

### æœ¬ç ”ç©¶å¡«è£œçš„ç¼ºå£

1. âœ… **å¤šæ¨™ç±¤åŒæ™‚é æ¸¬**ï¼ˆä¸‰é«˜åŒæ™‚é æ¸¬ï¼‰
2. âœ… **ç¸±å‘æ™‚åºç‰¹å¾µ**ï¼ˆÎ” è®ŠåŒ–é‡ï¼‰
3. âœ… **å°ç£æœ¬åœŸä¸‰é«˜ç¶œåˆç ”ç©¶**
4. âœ… **å¤šè³‡æ–™é›†é©—è­‰**ï¼ˆä¸­åœ‹ + åŠ æ‹¿å¤§ï¼‰

### æ€§èƒ½åŸºæº–ï¼ˆBenchmarkï¼‰

| ç–¾ç—… | AUC ç¯„åœ | åƒè€ƒæ–‡ç» |
|------|---------|---------|
| é«˜è¡€å£“ | 0.75-0.85 | Hung 2021 |
| ç³–å°¿ç—… | 0.76-0.99 | Liu 2024, Dual 2025, Chen 2023 |
| ä»£è¬ç—‡å€™ç¾¤ | 0.90-0.93 | ANN MetS 2006-14 |

**æœ¬ç ”ç©¶ç›®æ¨™**ï¼šAUC > 0.75, F1 > 0.65, Recall > 0.65

---

## ğŸ“– å¿«é€ŸæŸ¥æ‰¾

### æŒ‰ PDF æª”æ¡ˆä½ç½®æŸ¥æ‰¾

- [diagnostics-15-00072.pdf](../references/diagnostics-15-00072.pdf) â†’ Liu 2024 (ç³–å°¿ç—…) âœ…
- [diagnostics-15-02507.pdf](../references/diagnostics-15-02507.pdf) â†’ Dual 2025 (å‰é©…ç³–å°¿ç—…) ğŸ“Œ
- [fcvm-08-778306.pdf](../references/fcvm-08-778306.pdf) â†’ Hung 2021 (é«˜è¡€å£“) âš ï¸

### æŒ‰é—œéµè©æŸ¥æ‰¾

- **ç¸±å‘ç ”ç©¶ / Longitudinal**: Liu 2024, Dual 2025
- **SHAP**: Dual 2025
- **å°ç£è³‡æ–™**: Liu 2024, Dual 2025, Hung 2021
- **XGBoost**: Liu 2024, Hung 2021, Dual 2025
- **Î´ç‰¹å¾µ / Î”ç‰¹å¾µ**: Dual 2025
- **é¡åˆ¥ä¸å¹³è¡¡ / SMOTE**: Liu 2024, Hung 2021

---

**æ–‡æª”å»ºç«‹æ—¥æœŸ**ï¼š2025-11-13
**ç¶­è­·è€…**ï¼šç´€ä¼¯å–¬
**ä¸‹æ¬¡æ›´æ–°**ï¼šå®Œæˆ Dual 2025 æ·±åº¦è§£æå¾Œ

---

## ğŸ”— å¿«é€Ÿå°èˆª

- ğŸ“‚ [è¿”å› Literature Notes ç›®éŒ„](.)
- ğŸ“Š [æŸ¥çœ‹ Q2 å°ç£æ–‡ç»å›é¡§](../research_plans/Q2_Taiwan_Literature_Review.md)
- ğŸ“‹ [æŸ¥çœ‹ç³»çµ±æ€§æ–‡ç»å›é¡§](Systematic_Literature_Review.md)
- ğŸ¯ [æŸ¥çœ‹ Meeting 17 æº–å‚™è¨ˆç•«](../meeting_notes/Meeting_17_Preparation_Plan.md)
- ğŸ“– [æŸ¥çœ‹ Meeting 1-16 ç¸½çµ](../meeting_notes/Meeting_Summary_1-16.md)
